Skip to main content
Year archive

NeopharmCO.,LTD. — 2021 filings

All 19 regulatory filings released by NeopharmCO.,LTD. (092730) in 2021, sourced directly from the official regulator.

19 Filings
2021 Period
2021 filings (19)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2021-12-10 Korean
기타경영사항(특허권취득)(자율공시)(피부 보습 증진용 및 피부 장벽 개선용 화장료 조성물)
Regulatory Filings
2021-11-30 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2021
2021-11-05 Korean
기타경영사항(특허권취득)(자율공시)(피지의 과다분비 억제용 조성물)
Regulatory Filings
2021-11-03 Korean
기타경영사항(특허권취득)(자율공시)(항염용 조성물)
Regulatory Filings
2021-11-03 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2021
2021-08-06 Korean
기타경영사항(특허권취득)(자율공시)(피부 상태 개선용 조성물)
Regulatory Filings
2021-06-08 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2021
2021-05-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-25 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-17 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-10 Korean
주주총회소집결의
AGM Information
2021-03-02 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2020
2021-02-08 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2021-02-08 Korean